Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
Starting soon
Conditions studied: Bloodstream Infection, Sepsis, Septic Shock
In brief
The objective of the study is to determine the efficacy of the Microbio InfectID-BSI qPCR kit in a clinical laboratory environment using patient whole blood for pathogen detection and identification versus standard of care methods from blood culture. The objective of this study is to determine the sensitivity and specificity of the Microbio InfectID-BSI qPCR kit by the evaluation of clinical blood samples versus standard of care methods from blood culture.
Key facts
- Study ID
- NCT06531031
- Run by
- Microbio Co Ltd
- People needed
- 1500
- Starts
- 2025-08-01
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2025-07-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female of neonates (less than 1 month of age), paediatrics (between 1 month and 17 years of age) or adults (≥18 years of age).
- Admitted to ICU, Emergency Department, or other medical wards for acute illness with medical decision to perform blood culture for suspicion of bloodstream Infection.
- Two additional EDTA blood sample/s collected from one anatomical site and at the same time as blood culture (two EDTA samples to be collected where possible).
- EDTA blood volume is ≥1mL.
- EDTA blood sample is stored according to Microbio's stability requirements.
You may not qualify if…
- No suspicion of blood stream infection (BSI).
- Any inclusion criterion not met.
- Multiple EDTA blood samples from the same patient.
- EDTA blood sample not obtained from the same anatomical site and at the same time as the blood culture sample.
- Subject has had an antimicrobial drug administered through the same port or central line as is used to collect the specimen.
- EDTA blood samples that have not been stored according to Microbio's sample stability requirements.
- EDTA blood volume <1mL.
Where it is running
- Indiana University Hospital — Indianapolis, Indiana, United States
- University of Maryland — Baltimore, Maryland, United States
- TriCore Reference Laboratories — Albuquerque, New Mexico, United States
- Vanderbilt University Medical Centre — Nashville, Tennessee, United States
- Texas Children's Hospital — Houston, Texas, United States
- The Prince Charles Hospital — Chermside, Queensland, Australia
- The Princess Alexandra Hospital — Woolloongabba, Queensland, Australia
- Southwest Regional Laboratory, UK Health Security Agency, Bristol UK — Bristol, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.